PerMed is a Coordination and Support Action (CSA) of 27 partners representing key decision makers in research and research policy, industry, healthcare and patient organisations.
The Strategic Research and Innovation Agenda (SRIA) is based on an analysis of important recent strategic reports as well as interviews and consultations with experts and representatives of all relevant sectors important to the implementation of Personalised Medicine (PM).
Based on recent and future developments, the SRIA contains 35 recommendations clustered under five challenges. The SRIA also presents nine prioritised recommendations, which have the highest potential impact and outcome in facilitating the introduction of PM for the benefit of patients, citizens and society as a whole.
Read more: PerMed_SRIA (pdf)